Latest Press Releases

Middle-Class and Senior Citizens May Save Rs. 9,000 as GST Cut on Insurance Is Considered

In India, health insurance for senior citizens is an essential financial product. It protects older adults from hefty medical expenses and brings peace of mind to families. Recently, the government’s fresh deliberations on cutting the 18% Goods ...

Extrovis AG and Dr. Reddy's Announce the Launch of the Authorized Generic of Carac (Fluorouracil Cream), 0.5% in the U.S.

Extrovis AG Bahnhof Park 46340, Baar, Switzerland Media Relations Contact Madhu Marur madhu.marur@extrovis.com Press Release Extrovis AG and Dr. ...

Boehringer Ingelheim and Palatin Technologies to Develop Potential First-in-class Melanocortin Receptor Targeted Treatment for Patients With Retinal Diseases

· Collaboration strengthens Boehringer’s pipeline in Eye Health. · Many patients with diabetic retinopathy (DR) continue to experience vision loss or treatment fatigue, underscoring an unmet need. · Melanocortin ...

Abnormal Newborn Screening Results: What Parents Should Do Next

Every newborn undergoes screening in their first few days of life. It is a quick routine that mostly brings peace of mind. But for a small number of families, the results can be abnormal. An abnormal newborn screening opens the door to worry, ...

EAACI Launches Global Antibiotic Allergy Awareness Campaign at EAACI Congress 2025

ZURICH, Aug. 15, 2025 (GLOBE NEWSWIRE) -- EAACI has launched its Antibiotic Allergy Awareness Campaign during its 2025 Congress in Glasgow. The initiative begins a global effort to address mislabelling and its link to antimicrobial resistance ...

Middle-Class and Senior Citizens May Save Rs. 9,000 as GST Cut on Insurance Is Considered

In India, health insurance for senior citizens is an essential financial product. It protects older adults from hefty medical expenses and brings peace of mind to families. Recently, the government’s fresh deliberations on cutting the 18% Goods ...

OMRON Healthcare Issues National Call-to-Action on Routine At-Home Blood Pressure Monitoring in Response to New Guidelines

PR Newswire HOFFMAN ESTATES, Ill., Aug. 19, 2025 Guideline Emphasis on Earlier Treatment to Reduce Health, Dementia Risks Boosts Urgency to Keep Closer Watch on Blood Pressure OMRON innovations support 2025 guidelines on heart-brain ...

FGFR Inhibitors Market Set to Surge by 2034 as Targeted Cancer Therapies Transform Treatment Paradigms | DelveInsight

PR Newswire LAS VEGAS, Aug. 19, 2025 The FGFR inhibitors market is projected to witness substantial growth in the coming years, driven by the rising incidence of conditions such as urothelial carcinoma, cholangiocarcinoma, and ...

Restricted Blood Flow Speeds Tumor Growth by Aging the Immune System

PR Newswire NEW YORK, Aug. 19, 2025 NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Cutting off blood flow can prematurely age the bone marrow, weakening the immune system's ability to fight cancer, according to a new study from NYU Langone Health. ...

Cohen Veterans Network Tackles Rising Suicide Rate Among Military-Affiliated Women with New Toolkit for Clinicians

PR Newswire STAMFORD, Conn., Aug. 19, 2025 Developed with support from Face the Fight ® , new lethal means safety counseling toolkit addresses unique suicide prevention needs of women veterans and service members STAMFORD, Conn., Aug. ...

Myosin Therapeutics Awarded $4.5 Million NCI Bridge Grant to Advance Phase I Trial of MT-125 in Glioblastoma

PR Newswire JUPITER, Fla., Aug. 19, 2025 JUPITER, Fla., Aug. 19, 2025 /PRNewswire/ -- Myosin Therapeutics, a biotechnology company developing novel therapies for aggressive cancers, today announced it has been awarded a $4.5M Phase IIB ...

mPATH Partners with NC Health Centers and DHHS to Expand Colorectal Cancer Screening Access Across the State

PR Newswire WINSTON-SALEM, N.C., Aug. 19, 2025 Pilot program involving over 10,000 North Carolinians shows early signs of success WINSTON-SALEM, N.C., Aug. 19, 2025 /PRNewswire/ -- mPATH Health, an innovative digital health company, is ...

New Research Reveals Rural Young People Face Unique Digital Mental Health Challenges

PR Newswire SAN FRANCISCO, Aug. 19, 2025 Hopelab study finds rural young people less likely to access mental health apps and online therapy despite similar rates of depression and anxiety to suburban/urban peers SAN FRANCISCO, Aug. 19, ...

Antengene's ATG-022 (CLDN18.2 ADC) Granted Breakthrough Therapy Designation for the Treatment of Gastric/Gastroesophageal Junction Adenocarcinoma

PR Newswire SHANGHAI and HONG KONG, Aug. 19, 2025 SHANGHAI and HONG KONG, Aug. 19, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to ...

REGENXBIO Announces FDA Review Extension of BLA for RGX-121 to Treat Patients with MPS II

PR Newswire ROCKVILLE, Md., Aug. 18, 2025 ROCKVILLE, Md., Aug. 18, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that the U.S. Food and Drug Administration (FDA) extended its review timeline of the Biologics License ...

Allied NP Wellness and Primary Care Blazing New Trails with Brain Stimulation to Treat Depression and Optimize Mental Health

PR Newswire HOMESTEAD, Fla., Aug. 18, 2025 HOMESTEAD, Fla., Aug. 18, 2025 /PRNewswire/ -- Allied NP Wellness and Primary Care, a primary healthcare and wellness service provider, is the first in the Miami area to offer EXOMIND, a noninvasive ...

NJ Healthy Aging Summit to Spotlight Opioid Safety and Alternatives for Older Adults

PR Newswire ATLANTIC CITY, N.J., Aug. 18, 2025 ATLANTIC CITY, N.J., Aug. 18, 2025 /PRNewswire/ -- A conference presented next month by Partnership for a Drug-Free New Jersey will examine the keys to healthy aging and the challenges that ...

Pharmacy Barriers Block 30% of Telemedicine Patients With Opioid Use Disorder From Lifesaving Medication

PR Newswire ANN ARBOR, Mich, Aug. 18, 2025 A report from Workit Health, published in JAMA Network Open, reveals widespread pharmacy barriers patients face when attempting to fill their buprenorphine prescriptions. ANN ARBOR, Mich, Aug. ...

Hearing Aids Market Anticipated to Record US$ 45.68 billion by 2031 Due to Rising Geriatric Population | The Insight Partners

PR Newswire NEW YORK, Aug. 18, 2025 NEW YORK, Aug. 18, 2025 /PRNewswire/ -- As per a new, comprehensive report from The Insight Partners, the Hearing Aids Market is experiencing significant growth owing to an increasing old age population, ...

Genprex Receives Notice of Allowance for Multiple Patents for Reqorsa® Gene Therapy with PD-L1 and PD-1 Antibodies to Treat Cancers

PR Newswire AUSTIN, Texas, Aug. 18, 2025 Strengthens Intellectual Property Estate for REQORSA Oncology Program with Immune Checkpoint Inhibitors AUSTIN, Texas, Aug. 18, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") ...

Too Many U.S. Physicians Remain in the Dark About Nicotine and FDA-Authorized Smoke-Free Alternatives

PR Newswire STAMFORD, Conn., Aug. 18, 2025 New White Paper Reveals the Dangers This Poses to Adult Smokers Seeking Better Options STAMFORD, Conn., Aug. 18, 2025 /PRNewswire/ -- America's next urgent challenge in ending smoking is ...

Novo Nordisk lowers cost of Ozempic® to $499 per month for self-paying patients, in support of patient access to authentic, FDA-approved semaglutide medicines

PR Newswire PLAINSBORO, N.J., Aug. 18, 2025 PLAINSBORO, N.J., Aug. 18, 2025 /PRNewswire/ -- Novo Nordisk announced the launch of a new offer that enables self-paying, eligible, type 2 diabetes patients access to authentic, FDA-approved ...

Glycovax Pharma is granted a licence by the National Research Council of Canada to develop a vaccine to fight nosocomial disease related to Pseudomonas aeruginosa (Pa) infections

PR Newswire MONTREAL, Aug. 18, 2025 MONTREAL, Aug. 18, 2025 /PRNewswire/ - Pseudomonas aeruginosa (Pa) is a bacterium responsible for nosocomial infections and is often fatal when contracted by people living with cystic fibrosis. There is ...

Anixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial

PR Newswire SAN JOSE, Calif., Aug. 18, 2025 Fourth Cohort Receiving 30x Initial Dose with No Dose-Limiting Toxicities Observed to Date SAN JOSE, Calif., Aug. 18, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") ...

Retired Super Bowl Champion Malik Jackson Partners with BRAIN.ONE to Advance Mental Health and Brain Optimization in Athletes

PR Newswire LOS ANGELES, Aug. 18, 2025 LOS ANGELES, Aug. 18, 2025 /PRNewswire/ -- BRAIN.ONE, the AI-powered brain fitness platform revolutionizing mental health and human performance, today announced a strategic partnership with Super Bowl ...

Foresight Diagnostics Announces Publication of Landmark Study Demonstrating Prognostic Value of Ultrasensitive ctDNA-MRD Detection in Large B-Cell Lymphoma

PR Newswire BOULDER, Colo., Aug. 18, 2025 BOULDER, Colo., Aug. 18, 2025 /PRNewswire/ -- Foresight Diagnostics, a leader in ultrasensitive minimal residual disease (MRD) detection, today announced the publication of a landmark pooled analysis ...

Accord BioPharma Announces Commercial Launch of IMULDOSA® (ustekinumab-srlf) Prefilled Syringes at Lowest WAC Price Among Branded Biosimilars to STELARA® (ustekinumab)

PR Newswire RALEIGH, N.C., Aug. 18, 2025 Company's third biosimilar expands access to proven targeted biologic therapy with patient-centric support services and resources RALEIGH, N.C., Aug. 18, 2025 /PRNewswire/ -- Accord BioPharma, ...

STEALTH BIOTHERAPEUTICS RESUBMITS NEW DRUG APPLICATION FOR ELAMIPRETIDE FOR THE TREATMENT OF BARTH SYNDROME

PR Newswire NEEDHAM, Mass., Aug. 18, 2025 NEEDHAM, Mass., Aug. 18, 2025 /PRNewswire/ -- Stealth BioTherapeutics, a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for ...

Skyhawk Therapeutics Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany to Discover Novel RNA-Targeting Small Molecules for Neurological Disorders

PR Newswire BOSTON, Aug. 18, 2025 Skyhawk Therapeutics enters into an option agreement to grant Merck KGaA, Darmstadt, Germany, exclusive global rights to drug candidates pursued under the collaboration upon option exercise Total deal ...

FDA Grants Soligenix Orphan Drug Designation for the Treatment of Behçet's Disease after Reviewing Recent Phase 2 Clinical Study Results

PR Newswire PRINCETON, N.J., Aug. 18, 2025 Provides SGX945 Seven Years of U.S. Market Exclusivity Upon FDA Approval PRINCETON, N.J., Aug. 18, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage ...

From the Battlefield to the Delivery Room: The AAJT-S Offers New Hope for Maternal Survival from Postpartum Hemorrhage

PR Newswire BIRMINGHAM, Ala., Aug. 18, 2025 BIRMINGHAM, Ala., Aug. 18, 2025 /PRNewswire/ -- A newly published clinical study reveals a potential breakthrough in the treatment of refractory postpartum hemorrhage (PPH), the leading cause of ...

In a Major Win for Vanda, a Federal Appeals Court Overturns FDA's Order Denying Approval of Hetlioz for the Treatment of Jet Lag Disorder

PR Newswire WASHINGTON, Aug. 18, 2025 WASHINGTON, Aug. 18, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it secured a landmark victory over the U.S. Food and Drug Administration (FDA) in its ...

Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease

PR Newswire BURLINGTON, N.C., Aug. 18, 2025 Lumipulse® pTau-217/Beta Amyloid 42 Ratio now available nationwide through Labcorp BURLINGTON, N.C., Aug. 18, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and ...

Izalontamab Brengitecan (EGFRxHER3 ADC) Granted Breakthrough Therapy Designation by U.S. FDA for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer

PR Newswire REDMOND, Wash. and PRINCETON, N.J., Aug. 18, 2025 REDMOND, Wash. and PRINCETON, N.J., Aug. 18, 2025 /PRNewswire/ -- SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, and Bristol Myers Squibb (NYSE: BMY) today ...

Echosens and Novo Nordisk Advance Partnership to Increase Awareness and Early Diagnosis of MASH

PR Newswire WESTBOROUGH, Mass., Aug. 18, 2025 WESTBOROUGH, Mass., Aug. 18, 2025 /PRNewswire/ -- Echosens, the leader in non-invasive liver diagnostics, and Novo Nordisk are strengthening their aligned efforts to combat steatotic liver ...

Latest Press Releases

Premium Press Releases »

Middle-Class and Senior Citizens May Save Rs. 9,000 as GST Cut on Insurance Is Considered

Extrovis AG and Dr. Reddy's Announce the Launch of the Authorized Generic of Carac (Fluorouracil Cream), 0.5% in the U.S.

Boehringer Ingelheim and Palatin Technologies to Develop Potential First-in-class Melanocortin Receptor Targeted Treatment for Patients With Retinal Diseases

Abnormal Newborn Screening Results: What Parents Should Do Next

EAACI Launches Global Antibiotic Allergy Awareness Campaign at EAACI Congress 2025

Press Releases »

Middle-Class and Senior Citizens May Save Rs. 9,000 as GST Cut on Insurance Is Considered

OMRON Healthcare Issues National Call-to-Action on Routine At-Home Blood Pressure Monitoring in Response to New Guidelines

FGFR Inhibitors Market Set to Surge by 2034 as Targeted Cancer Therapies Transform Treatment Paradigms | DelveInsight

Restricted Blood Flow Speeds Tumor Growth by Aging the Immune System

Cohen Veterans Network Tackles Rising Suicide Rate Among Military-Affiliated Women with New Toolkit for Clinicians

Myosin Therapeutics Awarded $4.5 Million NCI Bridge Grant to Advance Phase I Trial of MT-125 in Glioblastoma

mPATH Partners with NC Health Centers and DHHS to Expand Colorectal Cancer Screening Access Across the State

New Research Reveals Rural Young People Face Unique Digital Mental Health Challenges

Antengene's ATG-022 (CLDN18.2 ADC) Granted Breakthrough Therapy Designation for the Treatment of Gastric/Gastroesophageal Junction Adenocarcinoma

REGENXBIO Announces FDA Review Extension of BLA for RGX-121 to Treat Patients with MPS II

Allied NP Wellness and Primary Care Blazing New Trails with Brain Stimulation to Treat Depression and Optimize Mental Health

NJ Healthy Aging Summit to Spotlight Opioid Safety and Alternatives for Older Adults

Pharmacy Barriers Block 30% of Telemedicine Patients With Opioid Use Disorder From Lifesaving Medication

Hearing Aids Market Anticipated to Record US$ 45.68 billion by 2031 Due to Rising Geriatric Population | The Insight Partners

Genprex Receives Notice of Allowance for Multiple Patents for Reqorsa® Gene Therapy with PD-L1 and PD-1 Antibodies to Treat Cancers

Too Many U.S. Physicians Remain in the Dark About Nicotine and FDA-Authorized Smoke-Free Alternatives

Novo Nordisk lowers cost of Ozempic® to $499 per month for self-paying patients, in support of patient access to authentic, FDA-approved semaglutide medicines

Glycovax Pharma is granted a licence by the National Research Council of Canada to develop a vaccine to fight nosocomial disease related to Pseudomonas aeruginosa (Pa) infections

Anixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial

Retired Super Bowl Champion Malik Jackson Partners with BRAIN.ONE to Advance Mental Health and Brain Optimization in Athletes

Foresight Diagnostics Announces Publication of Landmark Study Demonstrating Prognostic Value of Ultrasensitive ctDNA-MRD Detection in Large B-Cell Lymphoma

Accord BioPharma Announces Commercial Launch of IMULDOSA® (ustekinumab-srlf) Prefilled Syringes at Lowest WAC Price Among Branded Biosimilars to STELARA® (ustekinumab)

STEALTH BIOTHERAPEUTICS RESUBMITS NEW DRUG APPLICATION FOR ELAMIPRETIDE FOR THE TREATMENT OF BARTH SYNDROME

Skyhawk Therapeutics Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany to Discover Novel RNA-Targeting Small Molecules for Neurological Disorders

FDA Grants Soligenix Orphan Drug Designation for the Treatment of Behçet's Disease after Reviewing Recent Phase 2 Clinical Study Results

From the Battlefield to the Delivery Room: The AAJT-S Offers New Hope for Maternal Survival from Postpartum Hemorrhage

In a Major Win for Vanda, a Federal Appeals Court Overturns FDA's Order Denying Approval of Hetlioz for the Treatment of Jet Lag Disorder

Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease

Izalontamab Brengitecan (EGFRxHER3 ADC) Granted Breakthrough Therapy Designation by U.S. FDA for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer

Echosens and Novo Nordisk Advance Partnership to Increase Awareness and Early Diagnosis of MASH